Indications and uses
To help assist with muscle, nerve and skeletal repair & regeneration
To help assist with muscle, nerve and skeletal repair & regeneration
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Anti-Interleukin-1 9 9X 200K, Ankle articulation 6X 200K, Articular capsule 8X 200K, Brain Derived Neurotrophic Factor 10X 200K, Beta Endorphin 9X 200K, bFibroblast Growth Factor 9X 200K, Coelliac Plexus 8X 200K,Calcitonin 8X 200K, Frontal lobe 8X 200K, Hip articulation 8X 200K, Hippocampus 8X 200K, Hypothalamus 8X 200K, Insulin-like Growth factor 11X 200K, Interleukin-10 12X 200K, Muscle 6X 200K, Nerve 8X 200K, Spinal cord 6X 200K, Sympathetic trunk 8X 200K, Transforming Growth Factor-Beta 10X 200K,
Anti-Interleukin-1 | Anti-inflammation |
Ankle articulation | Regeneration |
Articular capsule | Regeneration |
Brain Derived Neurotrophic Factor | Regeneration |
Beta Endorphin | Pain relief |
bFibroblast Growth Factor | Regeneration |
| Coelliac Plexus | Regeneration |
| Calcitonin | Calcium balance |
| Frontal lobe | Regeneration |
| Hip articulation | Regeneration |
| Hippocampus | Regeneration |
| Hypothalamus | Regeneration |
| Insulin-like Growth factor | Regeneration |
| Interleukin-10 | Anti-inflammation |
| Muscle | Regeneration |
| Nerve | Regeneration |
| Spinal cord | Regeneration |
| Sympathetic trunk | Regeneration |
| Transforming Growth Factor-Beta | Regeneration |
To help assist with muscle, nerve and skeletal repair & regeneration
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
Alcohol and Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0420
NDC 63776-347-15
Homeopathic remedy
MuSkel
• To help assist with muscle, nerve and skeletal repair & regeneration
Oral spray
50ml 1.7 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

MuSkel
50 mL
1.7 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0420
NDC: 63776-347-15
INDICATIONS:
To help assist with muscle, nerve and skeletal repair & regeneration
DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Inccorporated.
www.viatrexx.com
Newark, DE 19713

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-347-15 | 2024-01-30 | C162847 | 48780-1 | 1030e365-474c-111a-e063-dadaa90a10e2 | MuSkel |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-347-15 | MuSkel | 1 in 1 BOX | SPRAY | 1 | 5 | |
| 63776-347-15 | MuSkel | 50 mL in 1 BOTTLE, SPRAY | SPRAY | 50 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-347 | MUSKEL (ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT, BOS TAURUS ANKLE JOINT, SUS SCROFA ANKLE JOINT, BOS TAURUS JOINT CAPSULE, SUS SCROFA JOINT CAPSULE, BRAIN-DERIVED NEUROTROPHIC FACTOR HUMAN, METENKEFALIN, ERSOFERMIN, BOS TAURUS SOLAR PLEXUS, SUS SCROFA SOLAR PLEXUS, CALCITONIN, BOS TAURUS FRONTAL LOBE, SUS SCROFA FRONTAL LOBE, BOS TAURUS HIP JOINT, SUS SCROFA HIP JOINT, BOS TAURUS HIPPOCAMPUS, SUS SCROFA HIPPOCAMPUS, BOS TAURUS HYPOTHALAMUS, SUS SCROFA HYPOTHALAMUS, MECASERMIN RINFABATE) SPRAY [VIATREXX BIO INCORPORATED] | 5 | Legacy NDC, 2 package rows | 20221202_0d25eb9f-7b90-ddb7-8b50-9208550a78c5.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE INGREDIENT | ML4QRZ1HCL | 1 | |
| Beef | ACTIVE INGREDIENT | 4PIB2155QP | 1 | |
| Bos Taurus Ankle Joint | ACTIVE INGREDIENT | 63Z8OTG0HU | 1 | |
| Bos Taurus Frontal Lobe | ACTIVE INGREDIENT | R8970AT87X | 1 | |
| Bos Taurus Hip Joint | ACTIVE INGREDIENT | Y8426REN4E | 1 | |
| Bos Taurus Hippocampus | ACTIVE INGREDIENT | 4UQ8473K2W | 1 | |
| Bos Taurus Hypothalamus | ACTIVE INGREDIENT | S6G2NLH4Y7 | 1 | |
| Bos Taurus Joint Capsule | ACTIVE INGREDIENT | 782I3O9VSM | 1 | |
| Bos Taurus Nerve | ACTIVE INGREDIENT | 28G2U3MQJK | 1 | |
| Bos Taurus Solar Plexus | ACTIVE INGREDIENT | Y8H8S1X8IB | 1 | |
| Bos Taurus Spinal Cord | ACTIVE INGREDIENT | 03Z3I85RNE | 1 | |
| Bos Taurus Sympathetic Nerve | ACTIVE INGREDIENT | WU6MQV435F | 1 | |
| Brain-derived Neurotrophic Factor Human | ACTIVE INGREDIENT | 7171WSG8A2 | 1 | |
| Calcitonin | ACTIVE INGREDIENT | DF35I47HCM | 1 | |
| Ersofermin | ACTIVE INGREDIENT | 1NWT5SW3NW | 1 | |
| Interleukin-10 | ACTIVE INGREDIENT | 9SC4O216V9 | 1 | |
| Mecasermin Rinfabate | ACTIVE INGREDIENT | NZ8M50KKRG | 1 | |
| Metenkefalin | ACTIVE INGREDIENT | 9JEZ9OD3AS | 1 | |
| Pork | ACTIVE INGREDIENT | O138UB266J | 1 | |
| Sus Scrofa Ankle Joint | ACTIVE INGREDIENT | 654134QUOV | 1 | |
| Sus Scrofa Frontal Lobe | ACTIVE INGREDIENT | GV54Q19G55 | 1 | |
| Sus Scrofa Hip Joint | ACTIVE INGREDIENT | 519062UA90 | 1 | |
| Sus Scrofa Hippocampus | ACTIVE INGREDIENT | 5U2M8VE56F | 1 | |
| Sus Scrofa Hypothalamus | ACTIVE INGREDIENT | N6R0856Z79 | 1 | |
| Sus Scrofa Joint Capsule | ACTIVE INGREDIENT | LX0XHE5NLN | 1 | |
| Sus Scrofa Nerve | ACTIVE INGREDIENT | JXV50I6ZHK | 1 | |
| Sus Scrofa Solar Plexus | ACTIVE INGREDIENT | WN6M3MGG1X | 1 | |
| Sus Scrofa Spinal Cord | ACTIVE INGREDIENT | AVM99FC8AI | 1 | |
| Sus Scrofa Sympathetic Nerve | ACTIVE INGREDIENT | H6L0IFR3FE | 1 | |
| Transforming Growth Factor Beta-1 | ACTIVE INGREDIENT | T7D25J14LT | 1 | |
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE MOIETY | ML4QRZ1HCL | 1 | |
| Beef | ACTIVE MOIETY | 4PIB2155QP | 1 | |
| Bos Taurus Ankle Joint | ACTIVE MOIETY | 63Z8OTG0HU | 1 | |
| Bos Taurus Frontal Lobe | ACTIVE MOIETY | R8970AT87X | 1 | |
| Bos Taurus Hip Joint | ACTIVE MOIETY | Y8426REN4E | 1 | |
| Bos Taurus Hippocampus | ACTIVE MOIETY | 4UQ8473K2W | 1 | |
| Bos Taurus Hypothalamus | ACTIVE MOIETY | S6G2NLH4Y7 | 1 | |
| Bos Taurus Joint Capsule | ACTIVE MOIETY | 782I3O9VSM | 1 | |
| Bos Taurus Nerve | ACTIVE MOIETY | 28G2U3MQJK | 1 | |
| Bos Taurus Solar Plexus | ACTIVE MOIETY | Y8H8S1X8IB | 1 | |
| Bos Taurus Spinal Cord | ACTIVE MOIETY | 03Z3I85RNE | 1 | |
| Bos Taurus Sympathetic Nerve | ACTIVE MOIETY | WU6MQV435F | 1 | |
| Brain-derived Neurotrophic Factor Human | ACTIVE MOIETY | 7171WSG8A2 | 1 | |
| Calcitonin | ACTIVE MOIETY | DF35I47HCM | 1 | |
| Ersofermin | ACTIVE MOIETY | 1NWT5SW3NW | 1 | |
| Interleukin-10 | ACTIVE MOIETY | 9SC4O216V9 | 1 | |
| Mecasermin | ACTIVE MOIETY | 7GR9I2683O | 1 | |
| Metenkefalin | ACTIVE MOIETY | 9JEZ9OD3AS | 1 | |
| Pork | ACTIVE MOIETY | O138UB266J | 1 | |
| Sus Scrofa Ankle Joint | ACTIVE MOIETY | 654134QUOV | 1 | |
| Sus Scrofa Frontal Lobe | ACTIVE MOIETY | GV54Q19G55 | 1 | |
| Sus Scrofa Hip Joint | ACTIVE MOIETY | 519062UA90 | 1 | |
| Sus Scrofa Hippocampus | ACTIVE MOIETY | 5U2M8VE56F | 1 | |
| Sus Scrofa Hypothalamus | ACTIVE MOIETY | N6R0856Z79 | 1 | |
| Sus Scrofa Joint Capsule | ACTIVE MOIETY | LX0XHE5NLN | 1 | |
| Sus Scrofa Nerve | ACTIVE MOIETY | JXV50I6ZHK | 1 | |
| Sus Scrofa Solar Plexus | ACTIVE MOIETY | WN6M3MGG1X | 1 | |
| Sus Scrofa Spinal Cord | ACTIVE MOIETY | AVM99FC8AI | 1 | |
| Sus Scrofa Sympathetic Nerve | ACTIVE MOIETY | H6L0IFR3FE | 1 | |
| Transforming Growth Factor Beta-1 | ACTIVE MOIETY | T7D25J14LT | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-347 | 63776-347-15 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb5a2ac-5a14-7b02-e053-2a95a90a70dc | 0d25eb9f-7b90-ddb7-8b50-9208550a78c5 | 2022-11-30 | Warnings | eeb5a2ac-5a14-7b02-e053-2a95a90a70dc 0d25eb9f-7b90-ddb7-8b50-9208550a78c5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.